Vnitr Lek 1991, 37(3):255-260

[Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients].

R Dzúrik, K Dzúriková, V Spustová
Centrum klinickej farmakológie, Výskumný ústav lekárskej bioniky, Bratislava.

In a group of 19 patients selected at random, suffering from hypertension and signs of atherosclerosis of the coronary vessels glucose intolerance was revealed in 10 patients. Comparisons disclosed: a) Levels of immunoreactive insulin (IRI) rose more and declined more slowly in patients with glucose intolerance than in patients with glucose tolerance. b) The ratio IRI/glucose in plasma of patients with glucose intolerance increased less than in patients with satisfactory tolerance. c) 500 mg tolbutamide by the oral route reduced the blood sugar level during the first and second hour following administration of 75 mg glucose substantially more in patients with glucose intolerance. d) Tolbutamide reduced at the same time intervals also the rise of IRI levels, approximately equally in both groups of patients. e) Tolbutamide increased the IRI/glucose ratio during the investigated intervals. The authors conclude that a direct influence on glucose utilization in peripheral tissues is involved and an increased insulin sensitivity of skeletal muscles and other tissues after tolbutamide.

Keywords: Blood Glucose, analysis, ; Female; Glucose Tolerance Test; Humans; Hypertension, blood, ; Insulin, blood, ; Insulin Resistance; Male; Middle Aged; Tolbutamide, administration & dosage,

Published: March 1, 1991  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dzúrik R, Dzúriková K, Spustová V. [Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients]. Vnitr Lek. 1991;37(3):255-260.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.